Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene

BMC Medical Genetics

Volumn 14, Issue 1, 2013, Pages

  Djos, Anna ^a   Fransson, Susanne ^a   Kogner, Per ^b   Martinsson, Tommy ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Aneuploidy; Chromosomal instability; Neuroblastoma; Numerical aberrations; STAG2

Indexed keywords

CHROMOSOME PROTEIN; STAG2 PROTEIN; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CANCER PROGNOSIS; CHROMATID; CLINICAL ARTICLE; EXOME; EXON; FEMALE; GENE INACTIVATION; GENETIC ASSOCIATION; GENETIC CODE; HUMAN; HUMAN CELL; MALE; NEUROBLASTOMA; NEUROBLASTOMA CELL; POINT MUTATION; SEQUENCE ANALYSIS;

ANEUPLOIDY; ANTIGENS, NUCLEAR; CELL LINE, TUMOR; EXONS; HUMANS; NERVOUS SYSTEM NEOPLASMS; NEUROBLASTOMA; POINT MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 84884788143     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-14-102     Document Type: Article

References (19)

1. Gordon DJ, Resio B, Pellman D. Causes and consequences of aneuploidy in cancer. Nat Rev Genet 2012, 13(3):189-203.
2. Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT, Toretsky JA, Rosenberg SA, Shukla N, Ladanyi M, et al. Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 2011, 333(6045):1039-1043. 10.1126/science.1203619, 3374335, 21852505.
3. Carramolino L, Lee BC, Zaballos A, Peled A, Barthelemy I, Shav-Tal Y, Prieto I, Carmi P, Gothelf Y, Gonzalez De Buitrago G, et al. SA-1, a nuclear protein encoded by one member of a novel gene family: molecular cloning and detection in hemopoietic organs. Gene 1997, 195(2):151-159. 10.1016/S0378-1119(97)00121-2, 9305759.
4. Sumara I, Vorlaufer E, Gieffers C, Peters BH, Peters JM. Characterization of vertebrate cohesin complexes and their regulation in prophase. J Cell Biol 2000, 151(4):749-762. 10.1083/jcb.151.4.749, 2169443, 11076961.
5. Haering CH, Farcas AM, Arumugam P, Metson J, Nasmyth K. The cohesin ring concatenates sister DNA molecules. Nature 2008, 454(7202):297-301. 10.1038/nature07098, 18596691.
6. Caren H, Kryh H, Nethander M, Sjoberg RM, Trager C, Nilsson S, Abrahamsson J, Kogner P, Martinsson T. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. Proc Natl Acad Sci USA 2010, 107(9):4323-4328. 10.1073/pnas.0910684107, 2840092, 20145112.
7. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993, 11(8):1466-77.
8. Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009, 27:298-303. 10.1200/JCO.2008.16.6876, 2650389, 19047290.
9. Caren H, Erichsen J, Olsson L, Enerback C, Sjoberg RM, Abrahamsson J, Kogner P, Martinsson T. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene. BMC Genomics 2008, 9:353. 10.1186/1471-2164-9-353, 2527340, 18664255.
10. Caren H, Abel F, Kogner P, Martinsson T. High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours. Biochem J 2008, 416(2):153-159. 10.1042/BJ20081834, 18990089.
11. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25(14):1754-1760. 10.1093/bioinformatics/btp324, 2705234, 19451168.
12. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 2010, 20(9):1297-1303. 10.1101/gr.107524.110, 2928508, 20644199.
13. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010, 38(16):e164. 10.1093/nar/gkq603, 2938201, 20601685.
14. Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2013, 4(2):178-92.
15. Chung NG, Kim MS, Yoo NJ, Lee SH. Somatic mutation of STAG2, an aneuploidy-related gene, is rare in acute leukemias. Leuk Lymphoma 2012, 53(6):1234-1235. 10.3109/10428194.2011.645819, 22132872.
16. Kim MS, Kim SS, Je EM, Yoo NJ, Lee SH. Mutational and expressional analyses of STAG2 gene in solid cancers. Neoplasma 2012, 59(5):524-529. 10.4149/neo_2012_067, 22668012.
17. Molenaar JJ, Koster J, Zwijnenburg DA, van Sluis P, Valentijn LJ, van der Ploeg I, Hamdi M, van Nes J, Westerman BA, van Arkel J, et al. Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature 2012, 483(7391):589-93. 10.1038/nature10910, 22367537.
18. Cheung NK, Zhang J, Lu C, Parker M, Bahrami A, Tickoo SK, Heguy A, Pappo AS, Federico S, Dalton J, et al. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA 2012, 307(10):1062-71. doi:10.1001/jama.2012.228, 10.1001/jama.2012.228, 3527076, 22416102.
19. Sausen M, Leary RJ, Jones S, Wu J, Reynolds CP, Liu X, Blackford A, Parmigiani G, Diaz LA, Papadopoulos N, et al. Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma. Nat Genet 2013, 45(1):12-7. 3557959, 23202128.